Ad is loading...
BLRX
Price
$0.48
Change
+$0.02 (+4.35%)
Updated
Nov 15 closing price
One day until earnings call
EQ
Price
$0.71
Change
+$0.03 (+4.41%)
Updated
Nov 15 closing price
129 days until earnings call
Ad is loading...

BLRX vs EQ

Header iconBLRX vs EQ Comparison
Open Charts BLRX vs EQBanner chart's image
BioLineRx
Price$0.48
Change+$0.02 (+4.35%)
Volume$345.84K
CapitalizationN/A
Equillium
Price$0.71
Change+$0.03 (+4.41%)
Volume$127.34K
CapitalizationN/A
BLRX vs EQ Comparison Chart
Loading...
BLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
EQ
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BLRX vs. EQ commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLRX is a Sell and EQ is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (BLRX: $0.48 vs. EQ: $0.71)
Brand notoriety: BLRX and EQ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLRX: 101% vs. EQ: 67%
Market capitalization -- BLRX: $39.75M vs. EQ: $25.14M
BLRX [@Biotechnology] is valued at $39.75M. EQ’s [@Biotechnology] market capitalization is $25.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLRX’s FA Score shows that 0 FA rating(s) are green whileEQ’s FA Score has 1 green FA rating(s).

  • BLRX’s FA Score: 0 green, 5 red.
  • EQ’s FA Score: 1 green, 4 red.
According to our system of comparison, both BLRX and EQ are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLRX’s TA Score shows that 4 TA indicator(s) are bullish while EQ’s TA Score has 3 bullish TA indicator(s).

  • BLRX’s TA Score: 4 bullish, 4 bearish.
  • EQ’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, BLRX is a better buy in the short-term than EQ.

Price Growth

BLRX (@Biotechnology) experienced а +6.96% price change this week, while EQ (@Biotechnology) price change was -6.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

BLRX is expected to report earnings on Mar 26, 2025.

EQ is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLRX($39.8M) has a higher market cap than EQ($25.1M). EQ YTD gains are higher at: -1.853 vs. BLRX (-69.710). EQ has higher annual earnings (EBITDA): -7.68M vs. BLRX (-24.93M). BLRX has more cash in the bank: 40.1M vs. EQ (33.3M). EQ has less debt than BLRX: EQ (609K) vs BLRX (31.3M). EQ has higher revenues than BLRX: EQ (42.6M) vs BLRX (17M).
BLRXEQBLRX / EQ
Capitalization39.8M25.1M159%
EBITDA-24.93M-7.68M325%
Gain YTD-69.710-1.8533,761%
P/E RatioN/AN/A-
Revenue17M42.6M40%
Total Cash40.1M33.3M120%
Total Debt31.3M609K5,140%
FUNDAMENTALS RATINGS
BLRX vs EQ: Fundamental Ratings
BLRX
EQ
OUTLOOK RATING
1..100
2762
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9894
PRICE GROWTH RATING
1..100
6565
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EQ's Valuation (20) in the Biotechnology industry is in the same range as BLRX (37) in the Pharmaceuticals Other industry. This means that EQ’s stock grew similarly to BLRX’s over the last 12 months.

EQ's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BLRX (100) in the Pharmaceuticals Other industry. This means that EQ’s stock grew similarly to BLRX’s over the last 12 months.

EQ's SMR Rating (94) in the Biotechnology industry is in the same range as BLRX (98) in the Pharmaceuticals Other industry. This means that EQ’s stock grew similarly to BLRX’s over the last 12 months.

EQ's Price Growth Rating (65) in the Biotechnology industry is in the same range as BLRX (65) in the Pharmaceuticals Other industry. This means that EQ’s stock grew similarly to BLRX’s over the last 12 months.

EQ's P/E Growth Rating (100) in the Biotechnology industry is in the same range as BLRX (100) in the Pharmaceuticals Other industry. This means that EQ’s stock grew similarly to BLRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLRXEQ
RSI
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 11 days ago
86%
Declines
ODDS (%)
Bearish Trend 10 days ago
89%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Ad is loading...
BLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
EQ
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EIX83.681.55
+1.89%
Edison International
APLE15.50-0.09
-0.58%
Apple Hospitality REIT
DOYU10.41-0.12
-1.19%
DouYu International Holdings Limited
BZH33.30-1.33
-3.84%
Beazer Homes USA
OCX2.61-0.19
-6.79%
Oncocyte Corp

BLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLRX has been loosely correlated with ABCL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if BLRX jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLRX
1D Price
Change %
BLRX100%
+3.83%
ABCL - BLRX
34%
Loosely correlated
-3.99%
DWTX - BLRX
33%
Loosely correlated
-7.19%
INSM - BLRX
30%
Poorly correlated
-6.97%
IRON - BLRX
30%
Poorly correlated
-1.99%
SNPX - BLRX
30%
Poorly correlated
-8.05%
More

EQ and

Correlation & Price change

A.I.dvisor tells us that EQ and MTNB have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EQ and MTNB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EQ
1D Price
Change %
EQ100%
+3.71%
MTNB - EQ
32%
Poorly correlated
-2.27%
IMNM - EQ
32%
Poorly correlated
-11.09%
AUTL - EQ
27%
Poorly correlated
+2.33%
BLRX - EQ
24%
Poorly correlated
+3.83%
CMPX - EQ
24%
Poorly correlated
-13.21%
More